Product Information
QC TUSSIN DM 200-20 MG/20 ML is a generic product labeled by Chain Drug Marketing Association, priced at $0.0207 per ML under NDC 83324002504. Its NADAC has been published 97 times since Nov 27, 2024.
Strength
20; 200 mg/20mL; mg/20mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324002504
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
part341On Market Since
5/8/2024
Pharmacological Classes
Price Statistics
The NADAC for QC TUSSIN DM 200-20 MG/20 ML has been published 97 times since Nov 27, 2024, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0207 per ML |
|---|---|
| All-time high | $0.0207 (Sep 30, 2026) |
| All-time low | $0.0182 (Nov 27, 2024) |
| 52-week high | $0.0207 |
| 52-week low | $0.0197 |
| Median price | $0.0200 |
| Average price | $0.0197 |
| Largest weekly change | -3.8% (Apr 23, 2025) |
| Weeks tracked | 97 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC TUSSIN DM 200-20 MG/20 ML?
The current National Average Drug Acquisition Cost (NADAC) for QC TUSSIN DM 200-20 MG/20 ML, manufactured by Chain Drug Marketing Association, is $0.0207 per ML (NDC 83324002504), effective Sep 30, 2026.
How has the price of QC TUSSIN DM 200-20 MG/20 ML changed over time?
Over the history we have for it, the NADAC for QC TUSSIN DM 200-20 MG/20 ML has risen 13.4%. It has been tracked across 97 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for QC TUSSIN DM 200-20 MG/20 ML?
Since Nov 27, 2024, the NADAC for QC TUSSIN DM 200-20 MG/20 ML has ranged from a low of $0.0182 (Nov 27, 2024) to a high of $0.0207 (Sep 30, 2026), with a median of $0.0200 per ML.
Are there cheaper alternatives to QC TUSSIN DM 200-20 MG/20 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC TUSSIN DM LIQUID, is $0.0140 per ML — about 32% below QC TUSSIN DM 200-20 MG/20 ML.
Who manufactures QC TUSSIN DM 200-20 MG/20 ML?
QC TUSSIN DM 200-20 MG/20 ML (NDC 83324002504) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.